The Artois-Baillet Latour Foundation is a Belgian non-profit organization which was founded on 1 March 1974.
The foundation was born by the initiative of Count Alfred de Baillet Latour, who was the Director of the Artois Breweries in Leuven, Belgium. He was the last male heir of the old House of Baillet, and was by motherside related to the House of Spoelberch, who own the Artois Company. In 1995 the name was changed in Interbrew-Baillet Latour Foundation and in 2005, the name was changed to InBev-Baillet Latour Fund.
The Foundation wants to encourage and reward achievements of outstanding human value in the Arts and Sciences. It can do this by means of Prizes, or by any other means that the Foundation might deem appropriate.
The Artois-Baillet Latour Health Prize was established in 1977 to be awarded periodically to recognize the merits of a person whose work has contributed prominently to the improvement of human health in the fields of metabolic disorders, infectious diseases, neurological diseases, cancer and cardiovascular disease. Since 2000 the prize has been awarded annually. Worth 250,000 euros, it is Belgium's major scientific prize. Since 2005, it has been known as the InBev-Baillet Latour Health Prize.
Source: [1]
Stella Artois is a pilsner beer, first brewed in 1926 by Brouwerij Artois in Leuven, Belgium. In its original form, the beer is 5.2 per cent ABV, the country's standard for pilsners. The beer is also sold in other countries like the UK, Ireland, Canada and Australia, where it has a reduced ABV. Stella Artois is owned by Interbrew International B.V. which is a subsidiary of the world's largest brewer, Anheuser-Busch InBev SA/NV.
Leuven or Louvain is the capital and largest city of the province of Flemish Brabant in the Flemish Region of Belgium. It is located about 25 kilometres east of Brussels. The municipality itself comprises the historic city and the former neighbouring municipalities of Heverlee, Kessel-Lo, a part of Korbeek-Lo, Wilsele and Wijgmaal. It is the eighth largest city in Belgium with more than 100,244 inhabitants.
Peter Karel Piot, Baron Piot, KCMG, FRCP, FMedSci is a Belgian microbiologist known for his research into Ebola and AIDS. Piot is the director of the London School of Hygiene and Tropical Medicine.
Jean Bernard was a French physician and haematologist. He was professor of haematology and director of the Institute for Leukaemia at the University of Paris. After graduating in medicine in Paris in 1926 he commenced his laboratory training with the bacteriologist Gaston Ramon at the Pasteur Institute in 1929.
The National Fund for Scientific Research (NFSR) was once a government institution in Belgium for supporting scientific research until it was split into two separate organizations:
Désiré, Baron Collen is a Belgian physician, chemist, biotechnology entrepreneur and life science investor. He made several discoveries in thrombosis, haemostasis and vascular biology in many of which serendipity played a significant role. His main achievement has been his role in the development of tissue-type plasminogen activator (t-PA) from a laboratory concept to a life-saving drug for dissolving blood clots causing acute myocardial infarction or acute ischemic stroke. Recombinant t-PA was produced and marketed by Genentech Inc as Activase and by Boehringer Ingelheim GmbH as Actilyse, and is considered biotechnology's first life saving drug.
Bart De Strooper is a Belgian molecular biologist and professor at VIB and KU Leuven and the UK Dementia Research Institute and University College London, UK. His research interests are in Alzheimer's and other neurodegenerative diseases.
Michael Sela is an Israeli immunologist of Polish Jewish origin. He is the W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science in Rehovot. He is a former president of the Weizmann Institute of Science.
Viscount Philippe de Spoelberch is a Belgian businessman and dendrologist.
InBev is a brewing company that resulted from the merger between Belgium-based company Interbrew and Brazilian brewer AmBev which took place in 2004. It existed independently until the acquisition of Anheuser-Busch in 2008, which formed Anheuser-Busch InBev. InBev had operations in over 30 countries and sales in over 130 countries. In 2006, it had a market capitalization of €30.6 billion and net profit of €3.2 billion on sales of €13.3 billion.
The Leuven Centre for Global Governance Studies is an interfaculty interdisciplinary research centre of the Humanities and Social Sciences at KU Leuven, Belgium. It carries out and supports interdisciplinary research on topics related to globalization, global governance processes and multilateralism, and has been recognized as a KU Leuven Centre of Excellence.
Kari Kustaa Alitalo is a Finnish MD and a medical researcher. He is a foreign associated member of the National Academy of Sciences of the USA. He became famous for his discoveries of several receptor tyrosine kinases (RTKs) and the first growth factor capable of inducing lymphangiogenesis: vascular endothelial growth factor C (VEGF-C). In the years 1996–2007 he was Europe's second most cited author in the field of cell biology. Alitalo is currently serving as an Academy Professor for the Academy of Finland.
Sir Stephen Patrick O'Rahilly is an Irish-British physician and scientist known for his research into the molecular pathogenesis of human obesity, insulin resistance and related metabolic and endocrine disorders.
Alim Louis Benabid is a French-Algerian emeritus professor, neurosurgeon and member of the French Academy of Sciences, who has had a global impact in the development of deep brain stimulation (DBS) for Parkinson's disease and other movement disorders. He became emeritus professor of biophysics at the Joseph Fourier University in Grenoble in September 2007, and chairman of the board of the Edmond J. Safra Biomedical Research Center in 2009 at Clinatec, a multidisciplinary institute he co-founded in Grenoble that applies nanotechnologies to neurosciences.
The Max Delbrück Medal has been awarded annually since 1992 by the Max Delbrück Center for Molecular Medicine. Named after the German biophysicist Max Delbrück, it is presented in Berlin to an outstanding scientist on the occasion of the annual "Berlin Lecture on Molecular Medicine", which the MDC organizes together with other Berlin research institutions and Bayer HealthCare. The award recipient usually delivers a lecture after the award.
Jan Maria Florent Wouters is a Belgian academic. He is Jean Monnet Chair, and Professor of International Law and International Organizations at KU Leuven, where he is also Director of its Centre for Global Governance Studies and Institute for International Law.
Charles Moen Rice is an American virologist and Nobel Prize laureate whose main area of research is the Hepatitis C virus. He is a professor of virology at the Rockefeller University in New York City and an adjunct professor at Cornell University and Washington University School of Medicine. At the time of the award he was a faculty at Rockefeller.
The Research Foundation – Flanders is a Belgian public research council, based in Brussels. The Flemish research council aims to sponsor ground-breaking research and innovation. Much of this work involves supporting researchers and undertakings in association with the universities and institutes of Flanders, including Ghent University, University of Leuven, University of Antwerp and Free University of Brussels, among others.
Jean-François Borel is a Belgian microbiologist and immunologist who is considered one of the discoverers of cyclosporin.
Laurence Zitvogel is a French physician specializing in oncology and immunology with a large research experience in exosomes and the biological impact of those structures in malignant neoplasms.